FDA Class I Recall of Thyroid Medication Due to Excessive Hormone Dose

The FDA has escalated a recall of a thyroid medication to Class I, the most serious category, due to excessive hormone dosing that could cause serious health consequences or death. The specific product and manufacturer are not named in the report, and the scope of affected batches is unclear. This matters because Class I recalls indicate a significant public health risk, potentially affecting patients relying on thyroid hormone replacement therapy.